Popular Articles

2009 was peppy for mutual fund investors
Investors got the upper hand in 2009, as regulatory changes made mutual funds more attractive to park their money in even as the industry shrugged off recession blues with its assets hitting an all time high of Rs eight lakh crore.

Mandatory open offer for 100% stake in the works
Corporate acquisitions in India could become costlier, with market regulator Securities and Exchange Board of India (Sebi) mulling making it mandatory for acquirers to make an offer for up to 100 per cent stake in any listed company.

News of the day

UAE remains attractive choice of expatriate workers
The UAE remains a popular destination globally among expatriate workers as employment prospects have increased by up to 8.3 per cent annually and is expected to maintain its upbeat growth this year, a leading Middle East online recruitment portal has said.
Small Business

India Eco Summit: Pfizer to launch another product in India

World"s largest drug maker Pfizer today said it is in the process of bringing in synergies in operation with Wyeth, which it acquired in January this year, and will launch one more product by the end of this fiscal. - India Eco Summit: Sharma pitches for stimulus continuation - India Eco Summit: Fortis Healthcare to set up 3 more hospitals - India Eco Summit: "India at bottom half in man-woman equality index" - India Eco Summit: Ispat-Stemcor Rs 1,100-cr project to start soon - India Eco Summit: Kingfisher Airlines to raise $600 mn - India Eco Summit: ICICI to reduce stake in Firstsource "We have already introduced three products in the country in the last few months. Going forward we will be introducing one more product by the end of the current fiscal," Pfizer India Managing Director Keval Handa told reporters here on the sidelines of the India Economic Summit. Pfizer has recruited around 250 people this year for its India operations and will add another 200 to its tally next year. The company is also planning to expand to smaller cities. "To fuel the growth of Pfizer in India, we are also expanding our operations in tier-2 and tier-3 cities," Handa added. In January, Pfizer had acquired much smaller rival Wyeth for about $68 billion. Handa has also been appointed as Managing Director of Wyeth"s India operations. "As of now, Wyeth and Pfizer are two separate entities and they do not have major overlaps in terms of product portfolios and rather they complement each other," he added. The company is currently working on bringing synergies in operations of Pfizer and Wyeth in the country, he said. Asked about merger of Wyeth with Pfizer, Handa declined to comment.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):